Skip to main content
UniHealth

Doctor search

Faisal N Cheema, MD

Hematology/Oncology · Santa Clara

NPI 1740210194

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Office
1

Offices

1 location · Permanente Medical Group Inc · 10,928 clinicians in this group

Looking this up.

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheema’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Kaiser Permanente Dual Complete North P2 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Dual Complete North P23 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Basic Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026

State licence records

1 licence

  • Texas N2028Physician License · since 2009 · expires 2016-08-31
    Canc Non-RenewalNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Drugs they prescribed that Part D paid

$4,884,524

Pharmacies billed $4,884,524 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 6% of their Part D prescriptions (52 of 811) in 2024. Above the middle of the specialty; the typical hematology-oncology clinician is at 5%. Long-acting opioids: 21% of their opioid prescriptions.

501 generic and 310 brand-name prescriptions · $4,884,524 in drug cost · 39 antibiotic prescriptions to 18 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Calquence75$995,721$13,276
Pomalyst27$600,110$22,226
Imbruvica24$525,275$21,886
Jakafi32$450,647$14,083
Sprycel18$315,652$17,536
See all 22 drugs
Every Part D drug this clinician prescribed
Calquence75$995,721$13,276
Pomalyst27$600,110$22,226
Imbruvica24$525,275$21,886
Jakafi32$450,647$14,083
Sprycel18$315,652$17,536
Jaypirca16$308,070$19,254
Brukinsa25$282,223$11,289
Lenalidomide14$160,406$11,458
Venclexta13$114,410$8,801
Hydroxyurea69$2,388$35
Acyclovir79$1,953$25
Dexamethasone47$997$21
Imatinib Mesylate11$634$58
Morphine Sulfate Er11$609$55
Oxycodone24$519$22
Entecavir17$461$27
Prednisone40$371$9
Hydrocodone-Acetaminophen16$204$13
Gabapentin11$155$14
Sulfamethoxazole-Trimethoprim15$128$9
Allopurinol14$100$7
Alprazolam12$75$6

Year by year

Part D prescribing by year
20248111356% (52)38%$4,884,524
20237821446% (43)None$4,511,941
20227501354% (31)None$4,165,120
20216511053% (22)41%$2,983,263
20208501252% (18)46%$4,277,714
20198581293% (28)43%$3,570,873
20186641246% (37)None$1,853,360
2017561962% (11)28%$1,069,572
2016367735% (19)17%$348,618
201510932None14%$31,617
20142458027% (67)11%$24,825
20132818218% (51)None$63,006

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Calquence85$1,178,889$13,869
Pomalyst32$677,980$21,187
Imbruvica22$501,436$22,793
Sprycel20$335,414$16,771
Jakafi25$256,237$10,249
Promacta11$196,347$17,850
Jaypirca12$194,769$16,231
Brukinsa11$141,333$12,848
Acyclovir91$3,028$33
Hydroxyurea76$2,802$37
Dexamethasone55$1,993$36
Entecavir18$1,113$62
Oxycodone31$514$17
Prednisone34$461$14
Sulfamethoxazole-Trimethoprim12$126$10
Allopurinol15$110$7
Alprazolam15$96$6

2022: 21 drugs

Part D drugs prescribed in 2022
Calquence51$724,319$14,202
Imbruvica26$488,383$18,784
Pomalyst23$466,540$20,284
Xospata16$439,175$27,448
Calquence27$398,392$14,755
Revlimid15$266,449$17,763
Sprycel14$220,574$15,755
Promacta12$206,559$17,213
Xtandi16$198,086$12,380
Ninlaro12$162,594$13,550
Brukinsa12$151,988$12,666
Hydroxyurea72$3,487$48
Acyclovir86$3,260$38
Dexamethasone58$2,876$50
Abiraterone Acetate15$2,840$189
Prednisone29$283$10
Oxycodone14$248$18
Allopurinol17$165$10
Ondansetron15$142$9
Hydrocodone-Acetaminophen11$141$13
Alprazolam13$87$7

2021: 19 drugs

Part D drugs prescribed in 2021
Revlimid52$885,172$17,023
Pomalyst22$413,006$18,773
Imbruvica18$260,971$14,498
Promacta13$209,886$16,145
Xtandi20$209,758$10,488
Calquence14$207,801$14,843
Venclexta20$175,236$8,762
Sprycel11$165,214$15,019
Jakafi16$87,069$5,442
Procrit28$38,886$1,389
Abiraterone Acetate18$3,495$194
Hydroxyurea56$2,865$51
Acyclovir66$2,633$40
Dexamethasone23$1,202$52
Prednisone30$429$14
Levofloxacin22$258$12
Allopurinol20$193$10
Ondansetron12$130$11
Sulfamethoxazole-Trimethoprim14$119$8

2020: 21 drugs

Part D drugs prescribed in 2020
Revlimid100$1,754,411$17,544
Pomalyst18$357,030$19,835
Imbruvica22$286,379$13,017
Sprycel19$272,790$14,357
Venclexta26$272,348$10,475
Jakafi18$214,879$11,938
Ninlaro18$201,756$11,209
Calquence12$184,161$15,347
Promacta12$124,299$10,358
Procrit52$83,249$1,601
Zarxio20$40,619$2,031
Pradaxa19$5,081$267
Imatinib Mesylate21$4,394$209
Acyclovir78$3,409$44
Hydroxyurea45$2,612$58
Dexamethasone41$2,269$55
Voriconazole18$2,239$124
Allopurinol36$402$11
Levofloxacin19$297$16
Ondansetron31$280$9
Prednisone20$252$13

2019: 17 drugs

Part D drugs prescribed in 2019
Revlimid102$1,668,874$16,362
Imbruvica36$413,449$11,485
Pomalyst18$337,007$18,723
Sprycel21$286,260$13,631
Venclexta34$263,051$7,737
Jakafi15$194,468$12,965
Zarxio26$46,997$1,808
Pradaxa27$6,196$229
Imatinib Mesylate18$4,346$241
Dexamethasone45$2,749$61
Hydroxyurea43$2,305$54
Acyclovir62$1,833$30
Allopurinol39$500$13
Ondansetron55$451$8
Prednisone24$333$14
Levofloxacin13$205$16
Trazodone15$134$9

2018: 17 drugs

Part D drugs prescribed in 2018
Revlimid49$683,386$13,947
Jakafi14$262,599$18,757
Pomalyst14$233,797$16,700
Imbruvica17$194,595$11,447
Sprycel12$149,000$12,417
Leukeran15$11,534$769
Pradaxa21$4,440$211
Dexamethasone60$3,047$51
Hydroxyurea34$2,071$61
Acyclovir53$1,423$27
Ondansetron51$656$13
Allopurinol36$451$13
Prednisone37$391$11
Gabapentin15$266$18
Levothyroxine14$236$17
Oxycodone13$158$12
Trazodone13$91$7

2017: 14 drugs

Part D drugs prescribed in 2017
Revlimid27$311,621$11,542
Jakafi13$248,858$19,143
Pomalyst11$168,739$15,340
Zarxio26$57,539$2,213
Hydroxyurea45$3,538$79
Dexamethasone44$931$21
Acyclovir32$720$22
Ondansetron Odt14$452$32
Allopurinol31$419$14
Prednisone29$361$12
Ondansetron14$194$14
Ciprofloxacin17$189$11
Amlodipine Besylate18$101$6
Atenolol13$61$5

2016: 9 drugs

Part D drugs prescribed in 2016
Revlimid11$118,779$10,798
Acyclovir28$566$20
Allopurinol35$531$15
Dexamethasone14$311$22
Ciprofloxacin20$253$13
Prednisone17$224$13
Ondansetron12$204$17
Amlodipine Besylate15$108$7
Atenolol12$75$6

2015: 2 drugs

Part D drugs prescribed in 2015
Amlodipine Besylate14$205$15
Atenolol11$77$7

2014: 7 drugs

Part D drugs prescribed in 2014
Morphine Sulfate Er16$1,049$66
Oxycodone18$771$43
Hydrocodone-Acetaminophen18$375$21
Gabapentin14$354$25
Amlodipine Besylate13$199$15
Furosemide16$87$5
Atenolol11$77$7

2013: 10 drugs

Part D drugs prescribed in 2013
Letrozole15$655$44
Hydrocodone-Acetaminophen20$393$20
Oxycodone13$358$28
Amlodipine Besylate15$211$14
Promethazine13$196$15
Metformin13$110$8
Ciprofloxacin11$101$9
Atenolol13$88$7
Furosemide20$75$4
Prednisone14$45$3

Money from drug and device companies

$1,629 in 2025

Industry payments by year
202525$1,365$1,629
202412$1,000$1,068
202323None$187
202211None$14
202111None$21
202035None$99
201938None$634

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Genmab U.S.Epkinly$1,569
4 payments
  • Consulting for Epkinly · 2025-11-08 · $1,365
  • Meals for Epkinly · 2025-11-08 · $41
  • Travel for Epkinly · 2025-11-08 · $61
  • Meals for Epkinly · 2025-11-08 · $102
Imperative CareHotshot Controller$60
1 payment
  • Meals for Hotshot Controller · 2025-04-22 · $60
See all 5 published payments
Every published payment
Genmab U.S.Consulting · 2025-11-08Epkinly$1,365
Genmab U.S.Meals · 2025-11-08Epkinly$41
Genmab U.S.Travel · 2025-11-08Epkinly$61
Genmab U.S.Meals · 2025-11-08Epkinly$102
Imperative CareMeals · 2025-04-22Hotshot Controller$60
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $1,068

Payments by company in 2024
BTG InternationalVoraxaze$1,068
2 payments
  • Paid to speak or teach for Voraxaze · 2024-08-08 · $1,000
  • Meals for Voraxaze · 2024-07-26 · $68

2023: $187

Payments by company in 2023
BeiGene USABrukinsa$150
1 payment
  • Meals for Brukinsa · 2023-12-10 · $150
Pharmacyclics LLC An AbbVieEpkinly$37
2 payments
  • Meals for Epkinly · 2023-08-23 · $19
  • Meals for Imbruvica · 2023-02-14 · $17

2022: $14

Payments by company in 2022
E.R. Squibb & Sons L.L.C.Opdivo$14
1 payment
  • Education for Opdivo · 2022-10-20 · $14

2021: $21

Payments by company in 2021
AvingerPantheris$21
1 payment
  • Meals for Pantheris · 2021-06-08 · $21

2020: $99

Payments by company in 2020
W. L. Gore & AssociatesExcluder Aaa Endoprosthesis$60
3 payments
  • Meals for Excluder Aaa Endoprosthesis · 2020-10-07 · $21
  • Meals for Dryseal Flex Sheath · 2020-08-31 · $18
  • Meals for Excluder Aaa Endoprosthesis · 2020-01-22 · $21
Abbott LaboratoriesXience V Coronary Stent System$22
1 payment
  • Meals for Xience V Coronary Stent System · 2020-02-03 · $22
E.R. Squibb & Sons L.L.C.Opdivo$17
1 payment
  • Education for Opdivo · 2020-07-13 · $17

2019: $634

Payments by company in 2019
Silk Road MedicalEnroute Transcarotid Neuroprotection System$302
3 payments
  • Travel for Enroute Transcarotid Neuroprotection System · 2019-11-14 · $114
  • Travel for Enroute Transcarotid Neuroprotection System · 2019-11-13 · $136
  • Meals for Enroute Transcarotid Neuroprotection System · 2019-11-12 · $52
W. L. Gore & AssociatesViabahn Endoprosthesis With Heparin Bioactive Surface$216
4 payments
  • Meals for Excluder Aaa Endoprosthesis · 2019-10-25 · $28
  • Meals for Viabahn Endoprosthesis With Heparin Bioactive Surface · 2019-10-10 · $145
  • Meals for Excluder Aaa Endoprosthesis · 2019-10-09 · $14
  • Meals for Excluder Aaa Endoprosthesis · 2019-06-12 · $30
CelgenePomalyst$116
1 payment
  • Meals for Pomalyst · 2019-12-07 · $116

Professional record

NPI
1740210194
Licence
LA MD.204017, OH 35-086926, TX N2028Texas N2028: Canc Non-Renewal
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0003X (207RH0003X)
Mailing address
710 Lawrence Expy, Santa Clara, CA, 95051
NPI first listed
2006-07-03
NPI last updated
2025-02-05
NPI record certified
2025-02-05

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.